Conagra Brands, Inc. engages in the manufacture and sale of processed and packaged foods. It operates through the following segments: Grocery and Snacks, Refrigerated and Frozen, International ...

Megan Bullock, director of predictive science and strategic insights at Conagra, also pointed to the introduction of GLP-1 medications as something the company has paid special attention to.

In a report released yesterday, Matthew Smith, CFA from Stifel Nicolaus maintained a Hold rating on Conagra Brands (CAG – Research Report), with a price target of $28.00. The company’s shares ...